AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34819047 — intervention group
Group type: EXPERIMENTAL
Intervention: Education conditional cash transfer
Number of subjects: 0
Study 34819047 — intervention group
Group type: EXPERIMENTAL
Intervention: Wealth intervention
Number of subjects: 0
Study 34819047 — intervention group
Group type: EXPERIMENTAL
Intervention: Health intervention
Number of subjects: 0
Study 35357459 — intervention group
Group type: EXPERIMENTAL
Intervention: ePRO follow-up model
Number of subjects: 278
Study 35357459 — intervention group
Group type: COMPARATOR
Intervention: Traditional follow-up methods
Number of subjects: 278
Study 34393122 — intervention group
Group type: EXPERIMENTAL
Intervention: GC Fuji IX
Number of subjects: 160
Study 34393122 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-etch adhesive (nano-hybrid composite)
Number of subjects: 160
Study 34393122 — intervention group
Group type: EXPERIMENTAL
Intervention: Cention-N
Number of subjects: 160
Study 34393122 — intervention group
Group type: COMPARATOR
Intervention: Etch-and-rinse adhesive (nano-hybrid composite)
Number of subjects: 160
Study 36332541 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular midazolam (IM)
Number of subjects: 130
Study 36332541 — intervention group
Group type: COMPARATOR
Intervention: Intranasal midazolam (IN)
Number of subjects: 130
Study 32483928 — intervention group
Group type: EXPERIMENTAL
Intervention: Heated Humidified High Flow Nasal Cannula (HHHFNC)
Number of subjects: 64
Study 32483928 — intervention group
Group type: COMPARATOR
Intervention: Nasal Continuous Positive Airway Pressure (NCPAP)
Number of subjects: 64
Study 32483928 — intervention group
Group type: COMPARATOR
Intervention: NCPAP
Number of subjects: 64
Study 32483928 — intervention group
Group type: EXPERIMENTAL
Intervention: HHHFNC
Number of subjects: 64
Study 33333521 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Group (HIG) - 40% of maximum inspiratory pressure (MIP)
Number of subjects: 26
Study 33333521 — intervention group
Group type: COMPARATOR
Intervention: Low-Intensity Group (LIG) - 20% of maximum inspiratory pressure (MIP)
Number of subjects: 26
Study 33333521 — intervention group
Group type: COMPARATOR
Intervention: Comparison between HIG and LIG
Number of subjects: 26
Study 32560516 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 g/day CLA
Number of subjects: 74
Study 32560516 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 74
Study 35114581 — intervention group
Group type: EXPERIMENTAL
Intervention: ACLR patients
Number of subjects: 23
Study 35114581 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 23
Study 32799393 — intervention group
Group type: EXPERIMENTAL
Intervention: Dichotomous key for springs ecosystem classification
Number of subjects: 244
Study 36252412 — intervention group
Group type: EXPERIMENTAL
Intervention: ON-SXB 6 g
Number of subjects: 28
Study 36252412 — intervention group
Group type: COMPARATOR
Intervention: Twice-nightly SXB (two 3-g doses)
Number of subjects: 28
Study 36252412 — intervention group
Group type: EXPERIMENTAL
Intervention: ON-SXB and Twice-nightly SXB
Number of subjects: 28
Study 36266118 — intervention group
Group type: EXPERIMENTAL
Intervention: LSD (200 μg)
Number of subjects: 42
Study 36266118 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study 32854563 — intervention group
Group type: EXPERIMENTAL
Intervention: Isopropyl alcohol‐containing caps
Number of subjects: 95
Study 32854563 — intervention group
Group type: COMPARATOR
Intervention: Standard catheter caps
Number of subjects: 95
Study 32147436 — intervention group
Group type: COMPARATOR
Intervention: Cx32 deficiency (Cx32 knockout mice)
Number of subjects: 0
Study 32147436 — intervention group
Group type: EXPERIMENTAL
Intervention: Cx32 small interfering RNA and p53 inhibitor (pifithrin-α, tenovin-1)
Number of subjects: 0
Study 32147436 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 0
Study 36451052 — intervention group
Group type: EXPERIMENTAL
Intervention: HDS with HFNC platform
Number of subjects: 0
Study 36451052 — intervention group
Group type: EXPERIMENTAL
Intervention: HDS with HFNC platform (randomized breathing)
Number of subjects: 0
Study 36451052 — intervention group
Group type: EXPERIMENTAL
Intervention: HDS with OI platform (best-case mouthpiece)
Number of subjects: 0
Study 36451052 — intervention group
Group type: EXPERIMENTAL
Intervention: HDS with OI platform (normal vs. deep randomized oral inhalation)
Number of subjects: 0
Study 34046761 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV care for partners living with HIV
Number of subjects: 155
Study 34046761 — intervention group
Group type: EXPERIMENTAL
Intervention: PrEP care for HIV-negative partners
Number of subjects: 155
Study 34046761 — intervention group
Group type: COMPARATOR
Intervention: Racial comparison of viral suppression
Number of subjects: 155
Study 33098470 — intervention group
Group type: EXPERIMENTAL
Intervention: Edoxaban (60 mg/30 mg once daily) plus a P2Y12 inhibitor for 12 months
Number of subjects: 1506
Study 33098470 — intervention group
Group type: COMPARATOR
Intervention: Vitamin K antagonist (VKA) plus a P2Y12 inhibitor and aspirin (100 mg OD, for 1–12 months)
Number of subjects: 1506
Study 33098470 — intervention group
Group type: EXPERIMENTAL
Intervention: Not specified
Number of subjects: 1506
Study 35997037 — intervention group
Group type: EXPERIMENTAL
Intervention: Traction ESD (T-ESD)
Number of subjects: 251
Study 35997037 — intervention group
Group type: COMPARATOR
Intervention: Conventional ESD (C-ESD)
Number of subjects: 251
Study 35997037 — intervention group
Group type: EXPERIMENTAL
Intervention: Traction ESD (T-ESD) for lesions ≥30 mm
Number of subjects: 251
Study 35997037 — intervention group
Group type: COMPARATOR
Intervention: Conventional ESD (C-ESD) for lesions ≥30 mm
Number of subjects: 251
Study 35997037 — intervention group
Group type: EXPERIMENTAL
Intervention: Traction ESD (T-ESD) for non-expert operators
Number of subjects: 251
Study 35997037 — intervention group
Group type: COMPARATOR
Intervention: Conventional ESD (C-ESD) for non-expert operators
Number of subjects: 251
Study 34386935 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral pioglitazone 30 mg/day (Arm A)
Number of subjects: 90
Study 34386935 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Arm B)
Number of subjects: 90
Study 34799219 — intervention group
Group type: EXPERIMENTAL
Intervention: Ursolic acid (UA) 400 mg/day
Number of subjects: 27
Study 34799219 — intervention group
Group type: COMPARATOR
Intervention: Placebo 400 mg/day
Number of subjects: 27
Study 34155173 — intervention group
Group type: EXPERIMENTAL
Intervention: PhD-prepared nurse educators
Number of subjects: 160
Study 34155173 — intervention group
Group type: COMPARATOR
Intervention: DNP-prepared nurse educators
Number of subjects: 160
Study 34155173 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall skill acquisition scores
Number of subjects: 160
Study 34155173 — intervention group
Group type: EXPERIMENTAL
Intervention: Use assessment and evaluation domain
Number of subjects: 160
Study 34155173 — intervention group
Group type: EXPERIMENTAL
Intervention: Engage in scholarship domain
Number of subjects: 160
Study 32527322 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced care planning with clinical-community linkage support
Number of subjects: 600
Study 32527322 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 600
Study 34797378 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified vacuum‐formed retainers (mVFRs)
Number of subjects: 35
Study 34797378 — intervention group
Group type: COMPARATOR
Intervention: Hawley retainers (HRs)
Number of subjects: 35
Study 33561274 — intervention group
Group type: EXPERIMENTAL
Intervention: KEβHB-supplemented drink
Number of subjects: 18
Study 33561274 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 34551902 — intervention group
Group type: EXPERIMENTAL
Intervention: Arthroscopic Bankart
Number of subjects: 122
Study 34551902 — intervention group
Group type: COMPARATOR
Intervention: Open Latarjet
Number of subjects: 122
Study 35811545 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron supplementation (66 mg elemental iron daily as ferrous fumarate)
Number of subjects: 119
Study 35811545 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 119
Study 35811545 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron supplementation
Number of subjects: 119
Study 34328479 — intervention group
Group type: EXPERIMENTAL
Intervention: NBS (xenograft enriched with polymer and gelatin)
Number of subjects: 20
Study 34328479 — intervention group
Group type: COMPARATOR
Intervention: DBBM (deproteinized bovine bone mineral)
Number of subjects: 20
Study 34328479 — intervention group
Group type: COMPARATOR
Intervention: Comparison of NBS vs DBBM
Number of subjects: 20
Study 32410495 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioral intervention
Number of subjects: 54
Study 32410495 — intervention group
Group type: EXPERIMENTAL
Intervention: Relaxation-skills-only intervention
Number of subjects: 54
Study 32410495 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse self-efficacy
Number of subjects: 54
Study 32410495 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention adherence
Number of subjects: 54
Study 33337677 — intervention group
Group type: EXPERIMENTAL
Intervention: Matrix Rhythm Therapy (MRT) in addition to a combined physiotherapy program (hot pack, transcutaneous electrical nerve stimulation, therapeutic ultrasound, home exercise and patient education program)
Number of subjects: 32
Study 33337677 — intervention group
Group type: COMPARATOR
Intervention: Combined physiotherapy program (hot pack, transcutaneous electrical nerve stimulation, therapeutic ultrasound, home exercise and patient education program)
Number of subjects: 32
Study 33337677 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of delta values between groups
Number of subjects: 32
Study 32183835 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary residential nutritional rehabilitation programme
Number of subjects: 72
Study 32183835 — intervention group
Group type: COMPARATOR
Intervention: Standard care (wait-list control group)
Number of subjects: 72
Study 35010717 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-myofascial release technique (foam rolling)
Number of subjects: 62
Study 35010717 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 62
Study 32484068 — intervention group
Group type: EXPERIMENTAL
Intervention: Neurocognitive Temporal Training (NTT)
Number of subjects: 41
Study 32484068 — intervention group
Group type: COMPARATOR
Intervention: Control (no NTT training)
Number of subjects: 41
Study 36321799 — intervention group
Group type: EXPERIMENTAL
Intervention: aboBoNT‐A injections 600 U (n = 162) or 800 U (n = 161)
Number of subjects: 485
Study 36321799 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 162)
Number of subjects: 485
Study 36321799 — intervention group
Group type: EXPERIMENTAL
Intervention: aboBoNT‐A injections
Number of subjects: 485
Study 36321799 — intervention group
Group type: COMPARATOR
Intervention: aboBoNT‐A injections and placebo
Number of subjects: 485
Study 33787956 — intervention group
Group type: EXPERIMENTAL
Intervention: Soleus H-reflex amplitude modulation in iSCI individuals
Number of subjects: 10
Study 33787956 — intervention group
Group type: COMPARATOR
Intervention: Soleus H-reflex amplitude modulation in age-matched controls (CTRL)
Number of subjects: 10
Study 33787956 — intervention group
Group type: EXPERIMENTAL
Intervention: Balance control assessment using the Berg Balance Scale
Number of subjects: 10
Study 33787956 — intervention group
Group type: EXPERIMENTAL
Intervention: Center of pressure (CoP) displacement analysis
Number of subjects: 10
Study 35272494 — intervention group
Group type: EXPERIMENTAL
Intervention: Divalproex Sodium (VPA)
Number of subjects: 48
Study 35272494 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 34033974 — intervention group
Group type: EXPERIMENTAL
Intervention: Apatinib (500 mg/d) + Gefitinib (250 mg/d)
Number of subjects: 313
Study 34033974 — intervention group
Group type: COMPARATOR
Intervention: Placebo + Gefitinib (250 mg/d)
Number of subjects: 313
Study 34033974 — intervention group
Group type: EXPERIMENTAL
Intervention: Apatinib + Gefitinib
Number of subjects: 313
Study 34033974 — intervention group
Group type: COMPARATOR
Intervention: Placebo + Gefitinib
Number of subjects: 313
Study 32441760 — intervention group
Group type: EXPERIMENTAL
Intervention: HOLA intervention
Number of subjects: 166
Study 32441760 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 166
Study 34048943 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 261
Study 34048943 — intervention group
Group type: COMPARATOR
Intervention: Nurse care management focused on analgesic treatment and optimization (MED)
Number of subjects: 261
Study 32143611 — intervention group
Group type: EXPERIMENTAL
Intervention: Video case modality
Number of subjects: 45
Study 32143611 — intervention group
Group type: COMPARATOR
Intervention: Paper case modality
Number of subjects: 45
Study 616783058 — intervention group
Group type: EXPERIMENTAL
Intervention: Yiqi Huoxue Tongmai decoction
Number of subjects: 95
Study 33210299 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose oral thiamine (600-1800 mg/d) for 4 weeks
Number of subjects: 40
Study 33210299 — intervention group
Group type: COMPARATOR
Intervention: Oral placebo for 4 weeks
Number of subjects: 40
Study 32772019 — intervention group
Group type: EXPERIMENTAL
Intervention: mHealth with interactivity (mHealth application + nurse case management supported by a social service team)
Number of subjects: 282
Study 32772019 — intervention group
Group type: EXPERIMENTAL
Intervention: mHealth (mHealth application only)
Number of subjects: 282
Study 32772019 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 282
Study 35485626 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimedia training programme for pain management (communication skills, assertiveness, stress management, lifestyle enhancement skills, physical activity)
Number of subjects: 0
Study 35485626 — intervention group
Group type: COMPARATOR
Intervention: Routine training (physician's visits, medication prescriptions, recommendations from healthcare providers)
Number of subjects: 0
Study 33091618 — intervention group
Group type: EXPERIMENTAL
Intervention: 5.25 % NaOCl + 17 % EDTA
Number of subjects: 40
Study 33091618 — intervention group
Group type: COMPARATOR
Intervention: Chlorhexidine (CHX)
Number of subjects: 40
Study 33091618 — intervention group
Group type: EXPERIMENTAL
Intervention: 3.8 % Silver diamine fluoride (SDF)
Number of subjects: 40
Study 33091618 — intervention group
Group type: EXPERIMENTAL
Intervention: Photodynamic therapy (PDT)
Number of subjects: 40
Study 36384935 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative bathing using plain soap
Number of subjects: 252
Study 36384935 — intervention group
Group type: COMPARATOR
Intervention: Control group (no preoperative bathing)
Number of subjects: 252
Study 36384935 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative bathing using plain soap among participants not given preoperative antibiotics
Number of subjects: 252
Study 33709251 — intervention group
Group type: EXPERIMENTAL
Intervention: Microabrasion with 35% phosphoric acid and pumice
Number of subjects: 15
Study 33709251 — intervention group
Group type: EXPERIMENTAL
Intervention: Microabrasion with 6.6% hydrochloric acid and silica
Number of subjects: 15
Study 33709251 — intervention group
Group type: EXPERIMENTAL
Intervention: 16% carbamide peroxide
Number of subjects: 15
Study 33709251 — intervention group
Group type: EXPERIMENTAL
Intervention: 35% H2O2
Number of subjects: 15
Study 36481801 — intervention group
Group type: EXPERIMENTAL
Intervention: Deceptive placebo (DP)
Number of subjects: 109
Study 36481801 — intervention group
Group type: EXPERIMENTAL
Intervention: Open-label placebo (OLP)
Number of subjects: 109
Study 36481801 — intervention group
Group type: COMPARATOR
Intervention: No treatment (NT)
Number of subjects: 109
Study 34609495 — intervention group
Group type: EXPERIMENTAL
Intervention: Deutetrabenazine (maximum total daily dose of 48 mg/d)
Number of subjects: 119
Study 34609495 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 119
Study 34609495 — intervention group
Group type: EXPERIMENTAL
Intervention: Deutetrabenazine
Number of subjects: 119
Study 32572777 — intervention group
Group type: EXPERIMENTAL
Intervention: Salvianolate
Number of subjects: 149
Study 32572777 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 149
Study 35314069 — intervention group
Group type: EXPERIMENTAL
Intervention: Evolocumab
Number of subjects: 74
Study 35314069 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 74
Study 35331945 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient navigation program - Pathways to Genetic Counseling
Number of subjects: 161
Study 35331945 — intervention group
Group type: COMPARATOR
Intervention: Care as usual (no contact)
Number of subjects: 161
Study 32899030 — intervention group
Group type: EXPERIMENTAL
Intervention: Thread embedding acupuncture (TEA), 6 treatments over 6 weeks (1 time/week) on 14 defined knee areas.
Number of subjects: 40
Study 32899030 — intervention group
Group type: COMPARATOR
Intervention: Acupuncture treatment, 12 treatments over 6 weeks (2 times/week) on 9 defined acupuncture points.
Number of subjects: 40
Study 35472333 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal fentanyl 100 mcg
Number of subjects: 107
Study 35472333 — intervention group
Group type: COMPARATOR
Intervention: Intranasal placebo
Number of subjects: 107
Study 33932433 — intervention group
Group type: EXPERIMENTAL
Intervention: Single flagellar motor driving cell-body rotation; specific dosage and duration not mentioned.
Number of subjects: 0
Study 33932433 — intervention group
Group type: EXPERIMENTAL
Intervention: Flagellar bundles on glass surfaces; specific dosage and duration not mentioned.
Number of subjects: 0
Study 35346849 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 g of intravenous tranexamic acid
Number of subjects: 89
Study 35346849 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 89
Study 33027073 — intervention group
Group type: EXPERIMENTAL
Intervention: EWSR1 rearrangement detected by FISH
Number of subjects: 94
Study 33027073 — intervention group
Group type: EXPERIMENTAL
Intervention: EWSR1 amplification
Number of subjects: 94
Study 33027073 — intervention group
Group type: EXPERIMENTAL
Intervention: Next-generation sequencing (NGS)
Number of subjects: 94
Study 33027073 — intervention group
Group type: EXPERIMENTAL
Intervention: PLAG1 rearrangement by FISH
Number of subjects: 94
Study 33027073 — intervention group
Group type: EXPERIMENTAL
Intervention: PLAG1 fusions found in NGS
Number of subjects: 94
Study 33027073 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall PLAG1 gene rearrangements
Number of subjects: 94
Study 33027073 — intervention group
Group type: EXPERIMENTAL
Intervention: EWSR1-ATF1 fusion
Number of subjects: 94
Study 33027073 — intervention group
Group type: EXPERIMENTAL
Intervention: ATF1 rearrangement by FISH
Number of subjects: 94
Study 35086119 — intervention group
Group type: EXPERIMENTAL
Intervention: Binocular treatment with Dig Rush game (1 h/d, 5 d/wk for 8 weeks)
Number of subjects: 182
Study 35086119 — intervention group
Group type: COMPARATOR
Intervention: Continued spectacle correction alone
Number of subjects: 182
Study 33147705 — intervention group
Group type: EXPERIMENTAL
Intervention: n-3 long-chain polyunsaturated fatty acids (n-3 PUFA) supplementation for six months
Number of subjects: 24
Study 33147705 — intervention group
Group type: COMPARATOR
Intervention: Placebo supplementation for six months
Number of subjects: 24
Study 34555964 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic Neuromuscular Stabilization (DNS) training
Number of subjects: 40
Study 34555964 — intervention group
Group type: COMPARATOR
Intervention: General Exercise (GE)
Number of subjects: 40
Study 32387716 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluid resuscitation protocols for children in DKA
Number of subjects: 1258
Study 34224363 — intervention group
Group type: EXPERIMENTAL
Intervention: Olaparib maintenance therapy after first-line chemotherapy (FL-M)
Number of subjects: 251
Study 34224363 — intervention group
Group type: EXPERIMENTAL
Intervention: Olaparib maintenance therapy after platinum-sensitive recurrence (PSR-M)
Number of subjects: 251
Study 34224363 — intervention group
Group type: EXPERIMENTAL
Intervention: Olaparib active treatment (AT)
Number of subjects: 251
Study 34224363 — intervention group
Group type: EXPERIMENTAL
Intervention: Olaparib (AT)
Number of subjects: 251
Study 34224363 — intervention group
Group type: EXPERIMENTAL
Intervention: Olaparib (PSR-M)
Number of subjects: 251
Study 34224363 — intervention group
Group type: EXPERIMENTAL
Intervention: Olaparib
Number of subjects: 251
Study 33043821 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant zoster vaccine (RZV)
Number of subjects: 0
Study 33043821 — intervention group
Group type: COMPARATOR
Intervention: Zoster vaccine live (ZVL)
Number of subjects: 0
Study 35771512 — intervention group
Group type: COMPARATOR
Intervention: 60-min PE sessions
Number of subjects: 160
Study 35771512 — intervention group
Group type: EXPERIMENTAL
Intervention: 90-min PE sessions
Number of subjects: 160
Study 32921199 — intervention group
Group type: EXPERIMENTAL
Intervention: Teach-back training method (TBTM) of respiratory exercise including diaphragmatic breathing (DB), pursed-lip breathing (PLB), and effective coughing (EC) plus routine approach
Number of subjects: 80
Study 32921199 — intervention group
Group type: EXPERIMENTAL
Intervention: Teach-back training method (TBTM) of respiratory exercise
Number of subjects: 80
Study 32921199 — intervention group
Group type: COMPARATOR
Intervention: Control group (routine approach)
Number of subjects: 80
Study 34619054 — intervention group
Group type: EXPERIMENTAL
Intervention: Pediatric Weight Management Intervention (PWMI)
Number of subjects: 0
Study 34619054 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased scores for exercising regularly
Number of subjects: 0
Study 34619054 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased scores for keeping healthy food at home
Number of subjects: 0
Study 33543216 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% lidocaine with 1∶100 000 EPI
Number of subjects: 21
Study 33543216 — intervention group
Group type: COMPARATOR
Intervention: 2% lidocaine with 1∶100 000 EPI
Number of subjects: 21
Study 36049498 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin therapy
Number of subjects: 154664
Study 36049498 — intervention group
Group type: EXPERIMENTAL
Intervention: More intensive statin regimens (40-80 mg atorvastatin or 20-40 mg rosuvastatin once per day)
Number of subjects: 154664